Laura L. Parks - 14 Jun 2021 Form 3 Insider Report for Recro Pharma, Inc.

Role
Director
Signature
/s/ Laura L. Parks
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
3
Filing time
21 Jun 2021, 07:56:53 UTC
Next filing
20 May 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.